Mallinckrodt Plc (NYSE:MNK)

127.18
Delayed Data
As of May 22
 -1.63 / -1.27%
Today’s Change
67.18
Today|||52-Week Range
134.26
+28.43%
Year-to-Date
No recent news for Mallinckrodt Plc.

Today’s Trading

Previous close128.81
Today’s open128.45
Day’s range127.11 - 129.04
Volume610,309
Average volume (3 months)1,292,534
Market cap$15.1B
Dividend yield--
Data as of 4:01pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+48.95%
Earnings growth (next 5 years)+17.80%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-0.08-0.09%
HSPHospira Inc-0.04-0.05%
JAZZJazz Pharmaceuticals...+2.28+1.26%
INCYIncyte Corp-0.72-0.66%
Data as of 4:03pm ET, 05/22/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)$1.80
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers